Skip to main content
. 2018 Jun 7;218(9):1447–1452. doi: 10.1093/infdis/jiy346

Figure 1.

Figure 1.

Immune parameters. (A) Western blot results, including individual bands and overall interpretation are given. The Fiebig stage according to these results is indicated. (B) Peripheral blood T-cell counts are plotted by time after exposure. Arrows indicate plasma human immunodeficiency virus (HIV)-1 ribonucleic acid tests, which all yielded undetectable viremia (<48 copies/mL for tests performed up to day 512, and <20 copies/mL for tests performed after day 512), with the exception of detected viremia below the linear range of quantitation on days 315 and 2868 (indicated by *). (C) Frequencies of CD8+ T-cell responses defined by enzyme-linked immune spot assay using a library of peptides spanning the HIV-1 subtype B sequence whole proteome are plotted. The number labels additionally indicate the number of epitope regions targeted at each time point (recognized 15-mer peptide in isolation or overlap between 2 consecutive overlapping 15-mer peptides). (D) Neutralizing antibody titers are expressed as 1/highest serum dilution to achieve 50% inhibitory concentration of the indicated Env-pseudotyped virions.